Replacement of the respiratory syncytial virus nonstructural proteins NS1 and NS2 by the V protein of parainfluenza virus 5

Virology

Volumn 368, Issue 1, 2007, Pages 73-82

  Tran, Kim C ^a   He, Biao ^a   Teng, Michael N ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Interferon antagonism; Nonstructural; Paramyxovirus

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; PROTEIN NS1; PROTEIN NS2; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN V;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PARAINFLUENZA VIRUS 5; PARAMYXOVIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA ISOLATION; VERO CELL; VIRUS EXPRESSION; VIRUS REPLICATION; WESTERN BLOTTING;

GENE DELETION; HUMANS; INTERFERON-BETA; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL NONSTRUCTURAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRULENCE; VIRULENCE FACTORS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; PARAINFLUENZA VIRUS; PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 35348944464     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.06.017     Document Type: Article

References (42)

1. Andrejeva J., Poole E., Young D.F., Goodbourn S., and Randall R.E. The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J. Virol. 76 22 (2002) 11379-11386
2. Andrejeva J., Young D.F., Goodbourn S., and Randall R.E. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76 5 (2002) 2159-2167
3. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., and Randall R.E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U.S.A. 101 49 (2004) 17264-17269
4. Atreya P.L., Peeples M.E., and Collins P.L. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J. Virol. 72 2 (1998) 1452-1461
5. Beeler J.A., and van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J. Virol. 63 7 (1989) 2941-2950
6. Bossert B., and Conzelmann K.K. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76 9 (2002) 4287-4293
7. Bossert B., Marozin S., and Conzelmann K.K. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77 16 (2003) 8661-8668
8. Buchholz U.J., Finke S., and Conzelmann K.K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73 1 (1999) 251-259
9. Bukreyev A., Whitehead S.S., Murphy B.R., and Collins P.L. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71 12 (1997) 8973-8982
10. Collins P.L., Hill M.G., Camargo E., Grosfeld H., Chanock R.M., and Murphy B.R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11563-11567
11. Collins P.L., Chanock R.M., and Murphy B.R. Respiratory syncytial virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 40 ed. (2001), Lippincott, Williams and Wilkins, Philadelphia 1443-1485
12. Conzelmann K.K. Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J. Virol. 79 9 (2005) 5241-5348
13. Didcock L., Young D.F., Goodbourn S., and Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73 12 (1999) 9928-9933
14. Evans J.E., Cane P.A., and Pringle C.R. Expression and characterisation of the NS1 and NS2 proteins of respiratory syncytial virus. Virus Res. 43 2 (1996) 155-161
15. Foy E., Li K., Sumpter Jr. R., Loo Y.M., Johnson C.L., Wang C., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., and Gale Jr. M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U.S.A. 102 8 (2005) 2986-2991
16. He B., Paterson R.G., Stock N., Durbin J.E., Durbin R.K., Goodbourn S., Randall R.E., and Lamb R.A. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303 1 (2002) 15-32
17. Hengst U., and Kiefer P. Domains of human respiratory syncytial virus P protein essential for homodimerization and for binding to N and NS1 protein. Virus Genes 20 3 (2000) 221-225
18. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 7034 (2005) 772-777
19. Horvath C.M. Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev. 15 2-3 (2004) 117-127
20. Jin H., Zhou H., Cheng X., Tang R., Munoz M., and Nguyen N. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology 273 1 (2000) 210-218
21. Kong X., San Juan H., Kumar M., Behera A.K., Mohapatra A., Hellermann G.R., Mane S., Lockey R.F., and Mohapatra S.S. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem. Biophys. Res. Commun. 306 2 (2003) 616-622
22. Lamb R.A., and Kolakofsky D. Paramyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 40 ed. (2001), Lippincott Williams and Wilkins, Philadelphia 1305-1340
23. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale Jr. M., and Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U.S.A. 102 8 (2005) 2992-2997
24. Lin Y., Horvath F., Aligo J.A., Wilson R., and He B. The role of simian virus 5 V protein on viral RNA synthesis. Virology 338 2 (2005) 270-280
25. Liu P., Jamaluddin M., Li K., Garofalo R.P., Casola A., and Brasier A.R. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 81 3 (2007) 1401-1411
26. Lo M.S., Brazas R.M., and Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79 14 (2005) 9315-9319
27. Murphy B.R., Sotnikov A.V., Lawrence L.A., Banks S.M., and Prince G.A. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8 5 (1990) 497-502
28. Parisien J.P., Lau J.F., and Horvath C.M. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76 13 (2002) 6435-6441
29. Poole E., He B., Lamb R.A., Randall R.E., and Goodbourn S. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303 1 (2002) 33-46
30. Ramaswamy M., Shi L., Monick M.M., Hunninghake G.W., and Look D.C. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 30 6 (2004) 893-900
31. Ramaswamy M., Shi L., Varga S.M., Barik S., Behlke M.A., and Look D.C. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344 2 (2006) 328-339
32. Rodriguez J.J., Cruz C.D., and Horvath C.M. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J. Virol. 78 10 (2004) 5358-5367
33. Schlender J., Bossert B., Buchholz U., and Conzelmann K.K. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74 18 (2000) 8234-8242
34. Spann K.M., Tran K.C., Chi B., Rabin R.L., and Collins P.L. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 78 8 (2004) 4363-4369
35. Spann K.M., Tran K.C., and Collins P.L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 79 9 (2005) 5353-5362
36. Teng M.N., and Collins P.L. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. J. Virol. 73 1 (1999) 466-473
37. Teng M.N., Whitehead S.S., Bermingham A., St Claire M., Elkins W.R., Murphy B.R., and Collins P.L. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J. Virol. 74 19 (2000) 9317-9321
38. Ulane C.M., and Horvath C.M. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304 2 (2002) 160-166
39. Whitehead S.S., Bukreyev A., Teng M.N., Firestone C.Y., St Claire M., Elkins W.R., Collins P.L., and Murphy B.R. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J. Virol. 73 4 (1999) 3438-3442
40. Wright P.F., Karron R.A., Madhi S.A., Treanor J.J., King J.C., O'Shea A., Ikizler M.R., Zhu Y., Collins P.L., Cutland C., Randolph V.B., Deatly A.M., Hackell J.G., Gruber W.C., and Murphy B.R. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J. Infect. Dis. 193 4 (2006) 573-581
41. Young D.F., Didcock L., Goodbourn S., and Randall R.E. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269 2 (2000) 383-390
42. Young D.F., Andrejeva L., Livingstone A., Goodbourn S., Lamb R.A., Collins P.L., Elliott R.M., and Randall R.E. Virus replication in engineered human cells that do not respond to interferons. J. Virol. 77 3 (2003) 2174-2181